French National Authority for Health (HAS) published new set of decisions by CNEDiMTS about add-on and medical aid reimbursement in June

French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 8 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS).

Three decisions were released for coronary stents:

• ULTIMASTER, drug-eluting coronary stent (request for amendment, approved)
• RESOLUTE ONYX, drug-eluting coronary stent (request for amendment, approved)
• BIOSS LIM C, drug-eluting bifurcation coronary stent (application for registration, approved)

Two decisions were published for portable oxygen concentrators:

• ZEN-O RS-00500, portable oxygen concentrator (application for registration, approved)
• XPO2, portable oxygen concentrator (application for renewal of registration, approved)

Three other decisions:

• UROLIFT, intra-prostatic implant (application for registration, approved)
• AXIUM, non-rechargeable implantable system for spinal ganglion stimulation (application for registration, approved)
• Insulin pumps  (request for amendment of technical specifications, approved)

See list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.